Mohammad K. Hamad

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Corrigendum: Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure.

Corrigendum: Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure.

Journal: Frontiers in cardiovascular medicine
Published: February 20, 2025

Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure.

Sodium-glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure.

Journal: Frontiers in cardiovascular medicine
Published: February 07, 2024

Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial.

Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial.

Journal: Frontiers in immunology
Published: January 13, 2024

SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis.

SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis.

Journal: Cellular signalling
Published: April 28, 2022

Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer.

Alpelisib-Induced Diabetic Ketoacidosis in a Patient With Metastatic Breast Cancer.

Journal: Cureus
Published: November 10, 2021

Corpus callosum hematoma, as a rare complication of COVID-19.

Corpus callosum hematoma, as a rare complication of COVID-19.

Journal: Clinical case reports
Published: July 16, 2021

COVID-19 Pneumonia Complicated by Seizure Due to Severe Hyponatremia.

COVID-19 Pneumonia Complicated by Seizure Due to Severe Hyponatremia.

Journal: Cureus
Published: June 11, 2021

Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.

Qatar Diabetes Mobile Application Trial (QDMAT): an open-label randomised controlled trial to examine the impact of using a mobile application to improve diabetes care in type 2 diabetes mellitus-a study protocol.

Journal: Trials
Published: May 23, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026